Top

BMC Primary Care

Published in:

Open Access 01-12-2020 | Correspondence

Recruiting people with severe mental illness through community pharmacies: real-world experiences from a UK study

Authors: Hannah Macfarlane, Ian Maidment

Published in: BMC Primary Care | Issue 1/2020

Abstract

Background

Proxy recruitment of patient participants through community pharmacies may be a valuable strategy to maximise participation. This paper focuses on the feasibility of such a recruitment strategy for research involving people who experience severe mental illness.

Methods

Fifty-three community pharmacies, including 50 ‘Research Ready’ pharmacies, were asked to recruit people with severe mental illness for participation in research. Pharmacists were asked to provide participant information to anyone presenting a prescription meeting specific criteria.

Results

Thirteen recruitment sites (25%) (from 4 distinct organisations) were approved to recruit patient participants. Eighty-five percent (n = 11) failed to recruit any potential participants.

Conclusions

Proxy recruitment of people with severe mental illness through community pharmacies was challenging with challenges in both pharmacy- and participant-recruitment. Further investigation into supporting community pharmacists’ engagement with recruiting patients with SMI as research participants is required.

Peytremann-Bridevaux I, Bordet J, Santschi V, Collet TH, Eggli M, Burnand B. Community-based pharmacies: an opportunity to recruit patients? Int J Public Health. 2013;58:319–322. Available from: https://doi.org/10.1007/s00038-012-0383-8.

Knoester PD, Belitser SV, Deckers CLP, Keyser A, Renier WO, Egberts ACG, et al. Recruitment of a cohort of lamotrigine users through community pharmacists: differences between patients who gave informed consent and those who did not. Pharmacoepidemiol Drug Saf. 2005;14(2):107–12.CrossRef

van Wieren-de Wijer DBMA. Maitland-van der Zee A-H, de Boer A, Stricker BHC, Kroon AA, de Leeuw PW, et al. Recruitment of participants through community pharmacies for a pharmacogenetic study of antihypertensive drug treatment. Pharm World Sci. 2009;31(2):158–64.

Royal Pharmaceutical Society. Evaluation of the Community Pharmacy Research Ready Accreditation Programme [Internet]. 2016. Available from: https://www.rpharms.com/Portals/0/RPS document library/Open access/Research/ResR Evaluation 2016.pdf.

Crilly P, Patel N, Ogunrinde A, Berko D, Kayyali R. Community pharmacists’ involvement in research in the United Kingdom. Pharmacy. 2017;5(3):48. Available from: https://doi.org/10.3390/pharmacy5030048.

Maidment ID, Damery S, Campbell N, Seare N, Fox C, Iliffe S, et al. Medication review plus person-centred care : a feasibility study of a pharmacy-health psychology dual intervention to improve care for people living with dementia. BMC psychiatry [internet]. 2018;18(340). Available from. https://doi.org/10.1186/s12888-018-1907-4.

Bell S, McLachlan AJ, Aslani P, Whitehead P, Chen TF. Community pharmacy services to optimise the use of medications for mental illness: a systematic review. Aust N Z Health Policy. 2005;2(1):29. Available from. https://doi.org/10.1186/1743-8462-2-29.CrossRef

Fejzic J, Knox K, Hattingh HL, Mey A, McConnell D, Wheeler AJ. Australian mental health consumers and carers expect more health management information from community pharmacy. Int J Pharm Pract. 2017;25:454–62.CrossRef

Rubio-Valera M, Chen TF, O’Reilly CL. New roles for pharmacists in community mental health care: a narrative review. Int J Environ Res Public Health. 2014;11(10):10967–90.CrossRef

10.

Phokeo V, Sproule B, Raman-Wilms L. Community pharmacists’ attitudes toward and professional interactions with users of psychiatric medication. Psychiatr Serv. 2004;55(12):1434–6.CrossRef

11.

Dawson H, Sutton J, Taylor DA. Recruitment of individuals with enduring mental health conditions for health services research: International Journal of Pharmacy Practice; 2010.

12.

Kaae S, Traulsen JM, Nørgaard LS. Customer interest in and experience with various types of pharmacy counselling - a qualitative study. Health Expect. 2014;17(6):852–62.CrossRef

13.

Woodall A, Morgan C, Sloan C, Howard L. Barriers to participation in mental health research: are there specific gender, ethnicity and age related barriers? BMC Psychiatry. 2010;10(1):103. Available from: https://doi.org/10.1186/1471-244X-10-103.

Title: Recruiting people with severe mental illness through community pharmacies: real-world experiences from a UK study
Authors: Hannah Macfarlane
Ian Maidment
Publication date: 01-12-2020
Publisher: BioMed Central
Published in: BMC Primary Care / Issue 1/2020
Electronic ISSN: 2731-4553
DOI: https://doi.org/10.1186/s12875-020-01243-5

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Recruiting people with severe mental illness through community pharmacies: real-world experiences from a UK study

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2020

Experiences of managerial accountability in Ethiopia’s primary healthcare system: a qualitative study

A cross-sectional study of Swiss ambulatory care services use by multimorbid patients in primary care in the light of the Andersen model

Accuracy of telephone triage in patients suspected of transient ischaemic attack or stroke: a cross-sectional study

Population segments as a tool for health care performance reporting: an exploratory study in the Canadian province of British Columbia

General practitioner strategies for managing patients with multimorbidity: a systematic review and thematic synthesis of qualitative research

Multimorbidity as a predictor of health service utilization in primary care: a registry-based study of the Catalan population